Parkinson's Disease Trial, Recruiting NCT03025334 Sponsor: University of Manitoba Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT03025334
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Parkinson's disease, meaning you have two or more of the main recognized symptoms and no other known cause for those symptoms.
  • You are able to read and sign a consent form agreeing to take part.
  • You are over 40 years old.
  • You are fluent in English.
  • You are willing to have your thinking and memory assessed by a specialist doctor.

Who may not be able to join:

  • You have dementia or significant memory problems, based on a standard cognitive test score below 18.
  • You have certain unusual movement or neurological symptoms that suggest a different condition from standard Parkinson's disease, such as involuntary jerking, difficulty with coordinated movements, abnormal eye movements, balance problems, or unusual sensory changes (confirm with trial site).
  • Your MRI brain scan shows abnormal results.
  • You have any metal implants in your body or a heart pacemaker.
  • You are currently pregnant or breastfeeding (women who could become pregnant will be tested before any MRI scan).
  • You have severe uncontrolled involuntary movements, particularly involving the head, that could affect scan quality.
  • You have severe high blood pressure.
  • You have a heart or cardiovascular condition.
  • You have a history of seizures, stroke, moderate to severe head injury, high pressure in the brain, severe headaches, or any other neurological condition that may affect seizure risk — or you take certain medications such as tricyclic antidepressants or antipsychotics that may lower the threshold for seizures.
  • You have another health condition that could significantly affect your body's chemical balance or increase seizure risk (confirm with trial site).
  • You have a family history of epilepsy.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 204-318-2566

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Manitoba
Registry
ClinicalTrials.gov
Start date
22 March 2017
Est. completion
31 August 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

cognitive performance in neuropsychological tests

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov